Practice manager Paula Manly of Oklahoma’s Tulsa Surgical Arts team is featured in February’s Behind The Scenes column
FDA gives its nod to Bristol-Myers Squibb’s PD-1 blocker Opdivo for advanced melanoma. This is the 2nd PD-1 blocker approved to treat melanoma.
Nonablative lasers may play a role in the treatment of relcalcitrant lupus miliaris disseminates faciei.
PSP Editor Denise Mann shares insights from her interview with David Pyott, chairman and CEO of Allergan, and Brent Saunders, CEO of Actavis.
Salvadore R. Salvo provides advice to cosmetic surgeons on defined benefit pension plans.
Scientists can now repurpose fibroblasts into functional melanocytes. The new technique may hold immediate and important implications for treating vitiligo and screening for melanoma.
PSP gets an exclusive scoop about what’s trending from RealSelf in our latest feature The PSP Pulse with RealSelf.
Post-op application of PICO Negative Pressure Wound Therapy results in significantly fewer wound healing complications following breast reduction surgery.
Roger S. Balser offers advice on how to take stock of your portfolio in the new year.
They say making predictions is a fool’s errand, but that doesn’t stop PSP editor Denise Mann from taking a stab at it.